273 related articles for article (PubMed ID: 15098089)
1. [Changes in muscarinic receptors of the aging bladder].
Andersson KE; Schröder A
Urologe A; 2004 May; 43(5):552-6. PubMed ID: 15098089
[TBL] [Abstract][Full Text] [Related]
2. [Changes in the receptor profile of the aging bladder].
Hampel C; Gillitzer R; Pahernik S; Melchior SW; Thüroff JW
Urologe A; 2004 May; 43(5):535-41. PubMed ID: 15112040
[TBL] [Abstract][Full Text] [Related]
3. Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies.
Hegde SS; Mammen M; Jasper JR
Curr Opin Investig Drugs; 2004 Jan; 5(1):40-9. PubMed ID: 14983972
[TBL] [Abstract][Full Text] [Related]
4. Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations.
Hashim H; Abrams P
Drugs; 2004; 64(15):1643-56. PubMed ID: 15257626
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic agonists and antagonists: effects on the urinary bladder.
Sellers DJ; Chess-Williams R
Handb Exp Pharmacol; 2012; (208):375-400. PubMed ID: 22222707
[TBL] [Abstract][Full Text] [Related]
6. [Overactive bladder--treatment with antimuscarinic agents].
Höfner K
Urologe A; 2003 Jun; 42(6):793-800. PubMed ID: 12851770
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic receptors in the bladder: from basic research to therapeutics.
Hegde SS
Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S80-7. PubMed ID: 16465186
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor antagonists for overactive bladder.
Abrams P; Andersson KE
BJU Int; 2007 Nov; 100(5):987-1006. PubMed ID: 17922784
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of the levels of expression of muscarinic receptor subtype RNA in the detrusor muscle of patients with overactive bladder.
Hinata N; Shirakawa T; Okada H; Achaya B; Kamidono S; Gotoh A
Mol Diagn; 2004; 8(1):17-22. PubMed ID: 15230638
[TBL] [Abstract][Full Text] [Related]
10. Human idiopathic and neurogenic overactive bladders and the role of M2 muscarinic receptors in contraction.
Stevens LA; Chapple CR; Chess-Williams R
Eur Urol; 2007 Aug; 52(2):531-8. PubMed ID: 17141942
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.
Abrams P; Andersson KE; Buccafusco JJ; Chapple C; de Groat WC; Fryer AD; Kay G; Laties A; Nathanson NM; Pasricha PJ; Wein AJ
Br J Pharmacol; 2006 Jul; 148(5):565-78. PubMed ID: 16751797
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.
Stevens LA; Sellers DJ; McKay NG; Chapple CR; Chess-Williams R
Auton Autacoid Pharmacol; 2006 Jul; 26(3):303-9. PubMed ID: 16879496
[TBL] [Abstract][Full Text] [Related]
13. Darifenacin in the treatment of overactive bladder.
Parsons M; Robinson D; Cardozo L
Int J Clin Pract; 2005 Jul; 59(7):831-8. PubMed ID: 15963212
[TBL] [Abstract][Full Text] [Related]
14. [Nerve growth factor as a biomarker in the diagnosis and treatment of overactive bladder (OAB)].
Jankiewicz K; Kulik-Rechberger B; Nowakowski Ł; Rechberger T
Ginekol Pol; 2012 Jul; 83(7):532-6. PubMed ID: 22880479
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic receptor subtypes and management of the overactive bladder.
Chapple CR; Yamanishi T; Chess-Williams R
Urology; 2002 Nov; 60(5 Suppl 1):82-8; discussion 88-9. PubMed ID: 12493364
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic receptors: what we know.
Scarpero HM; Dmochowski RR
Curr Urol Rep; 2003 Dec; 4(6):421-8. PubMed ID: 14622493
[TBL] [Abstract][Full Text] [Related]
17. Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.
Mansfield KJ; Chandran JJ; Vaux KJ; Millard RJ; Christopoulos A; Mitchelson FJ; Burcher E
J Pharmacol Exp Ther; 2009 Mar; 328(3):893-9. PubMed ID: 19029429
[TBL] [Abstract][Full Text] [Related]
18. Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations.
Mukerji G; Yiangou Y; Grogono J; Underwood J; Agarwal SK; Khullar V; Anand P
J Urol; 2006 Jul; 176(1):367-73. PubMed ID: 16753445
[TBL] [Abstract][Full Text] [Related]
19. Which muscarinic receptor is important in the bladder?
Yamanishi T; Chapple CR; Chess-Williams R
World J Urol; 2001 Nov; 19(5):299-306. PubMed ID: 11760777
[TBL] [Abstract][Full Text] [Related]
20. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
Kim Y; Yoshimura N; Masuda H; de Miguel F; Chancellor MB
Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
